This prediction market tracks whether the Trump administration will formally agree to Iranian uranium enrichment during April 2026. Uranium enrichment remains a central flashpoint in U.S.-Iran nuclear diplomacy, with international negotiations ongoing throughout 2026. The current 50% odds reflect traders' genuine uncertainty about whether hardline or diplomatic approaches will ultimately prevail in April's policy decisions. Market resolution depends on official U.S. government confirmation through public statements, diplomatic announcements, formal policy changes, or other verifiable channels. The April 30 deadline provides a clear resolution window for this specific month's outcome. Early April trading showed modest investor interest, with odds fluctuating between 45 and 55 percent as market participants respond to news flow and evolving diplomatic signals. At parity of 50 percent, the market clearly indicates traders are genuinely split on whether April will bring a significant policy shift toward uranium enrichment acceptance. Historical context demonstrates nuclear policy reversals are rare but not unprecedented, giving the balanced odds considerable credibility. The current price ultimately reflects both the inherent complexity of U.S.-Iran relations and the genuine uncertainty surrounding Trump administration priorities in April.